• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心力衰竭时癌胚抗原125不升高的预测因素

Predictive Factors of Non-Elevation of Carcinoembryonic Antigen 125 in Acute Heart Failure.

作者信息

López-Vilella Raquel, González-Vílchez Francisco, Guerrero Cervera Borja, Donoso Trenado Víctor, Saura Carretero Zoser, Martínez-Solé Julia, Huélamo Montoro Sara, Martínez Dolz Luis, Almenar Bonet Luis

机构信息

Cardiology Department, Hospital Universitari i Politècnic La Fe, Fernando Abril Martorell Avenue 106, 46026 Valencia, Spain.

Heart Failure and Transplant Unit, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.

出版信息

Life (Basel). 2025 Mar 18;15(3):494. doi: 10.3390/life15030494.

DOI:10.3390/life15030494
PMID:40141838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11944017/
Abstract

This study aims to analyze the factors associated with the lack of carbohydrate antigen 125 (CA-125) elevation in cases of acute heart failure (HF) decompensation. This retrospective study was conducted on 3167 consecutive patients admitted for acute HF in the cardiology department of a referral hospital (June 2019 to June 2024). Admissions from outpatient clinics (n: 1018) and transfers from other hospitals (n: 752) were excluded. The variables of interest included clinical, echocardiographic, therapeutic, and analytical factors. Low CA-125 levels were defined as values ≤ 50 U/mL. A total of 1397 patients were included, of whom 515 had normal CA-125 levels and 882 had elevated levels. Clinically, independent predictors of low CA-125 were sinus rhythm on electrocardiogram (OR: 1.42, 95% CI: 1.12-1.64; : 0.003) and sleep apnea-hyponpnea syndrome (OR: 1.76, 95% CI: 1.15-2.70; : 0.009). Echocardiographically, inferior vena cava collapse greater than 50% with inspiration was associated with low CA-125 (OR: 1.78, 95% CI: 1.19-2.69; = 0.005), as well as with non-severe right ventricular dysfunction. (OR: 2.42; IC95%: 1.39-4.20; : 0.002). Analytically, elevated NT-proBNP levels were associated with elevated CA-125 levels (OR: 0.99; IC95%: 0.99-0.99; : 0.006). Survival was higher in the group with CA-125 ≤ 50 U/mL (: 0.019). Conversely, as CA-125 values increased, mortality also rose. In conclusion, the absence of CA-125 elevation in patients admitted for acute HF is associated with sinus rhythm, sleep apnea-hyponpnea syndrome, low NT-proBNP levels, and inferior vena cava collapse greater than 50% with inspiration.

摘要

本研究旨在分析急性心力衰竭(HF)失代偿病例中与碳水化合物抗原125(CA - 125)未升高相关的因素。这项回顾性研究针对一家转诊医院心内科连续收治的3167例急性HF患者进行(2019年6月至2024年6月)。排除门诊入院患者(n = 1018)和从其他医院转入的患者(n = 752)。感兴趣的变量包括临床、超声心动图、治疗和分析因素。低CA - 125水平定义为≤50 U/mL。共纳入1397例患者,其中515例CA - 125水平正常,882例升高。临床上,低CA - 125的独立预测因素是心电图显示窦性心律(OR:1.42,95%CI:1.12 - 1.64;P = 0.003)和睡眠呼吸暂停低通气综合征(OR:1.76,95%CI:1.15 - 2.70;P = 0.009)。超声心动图方面,吸气时下腔静脉塌陷大于50%与低CA - 125相关(OR:1.78,95%CI:1.19 - 2.69;P = 0.005),也与非重度右心室功能障碍相关(OR:2.42;IC95%:1.39 - 【此处原文IC95%标注有误,推测应为95%CI】4.20;P = 0.002)。分析上,NT - proBNP水平升高与CA - 125水平升高相关(OR:0.99;IC95%:0.99 - 0.99;P = 0.006)。CA - 125≤50 U/mL组的生存率更高(P = 0.019)。相反,随着CA - 125值增加,死亡率也上升。总之,急性HF入院患者中CA - 125未升高与窦性心律、睡眠呼吸暂停低通气综合征、低NT - proBNP水平以及吸气时下腔静脉塌陷大于50%有关。 【说明:原文中部分表述如IC95%可能有误,推测应为95%CI,翻译时按推测修正后翻译,同时保留了原文中可能存在的错误表述供参考】

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/11944017/4211836aec74/life-15-00494-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/11944017/9fe7385d7ef4/life-15-00494-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/11944017/0b3e0b951dad/life-15-00494-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/11944017/d52f09614cda/life-15-00494-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/11944017/4211836aec74/life-15-00494-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/11944017/9fe7385d7ef4/life-15-00494-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/11944017/0b3e0b951dad/life-15-00494-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/11944017/d52f09614cda/life-15-00494-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/11944017/4211836aec74/life-15-00494-g004.jpg

相似文献

1
Predictive Factors of Non-Elevation of Carcinoembryonic Antigen 125 in Acute Heart Failure.急性心力衰竭时癌胚抗原125不升高的预测因素
Life (Basel). 2025 Mar 18;15(3):494. doi: 10.3390/life15030494.
2
The utility of inferior vena cava diameter and the degree of inspiratory collapse in patients with systolic heart failure.收缩性心力衰竭患者下腔静脉直径及吸气塌陷程度的效用
Am J Emerg Med. 2015 May;33(5):653-7. doi: 10.1016/j.ajem.2015.02.006. Epub 2015 Feb 9.
3
NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.NT-proBNP 和 CA125 水平与慢性心力衰竭患者冠状窦血清中促炎细胞因子的增加有关。
Cytokine. 2018 Nov;111:13-19. doi: 10.1016/j.cyto.2018.07.037. Epub 2018 Aug 8.
4
Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.糖类抗原125与N末端脑钠肽前体水平:用于心力衰竭预后评估的比较
Tex Heart Inst J. 2012;39(1):30-5.
5
Serum levels of carbohydrate antigen 125 in patients with heart failure and obstructive sleep apnea syndrome: a retrospective analysis.心力衰竭合并阻塞性睡眠呼吸暂停综合征患者血清糖类抗原125水平:一项回顾性分析
Cardiovasc Diagn Ther. 2023 Dec 15;13(6):994-1002. doi: 10.21037/cdt-23-323. Epub 2023 Dec 6.
6
Creatinine and NT-ProBNP levels could predict the length of hospital stay of patients with decompensated heart failure.肌酐和 NT-proBNP 水平可预测心力衰竭失代偿患者的住院时间。
Acta Cardiol. 2021 Dec;76(10):1100-1107. doi: 10.1080/00015385.2020.1871264. Epub 2021 Jan 22.
7
Clinical characteristics and predictors of in-hospital mortality in 270 consecutive patients hospitalised due to acute heart failure in a single cardiology centre during one year.270 例急性心力衰竭患者在单中心心内科住院期间的临床特征及院内死亡的预测因素分析。
Kardiol Pol. 2011;69(10):997-1005.
8
Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure.血清碳水化合物抗原 125 联合 N 端脑利钠肽前体在急性失代偿性心力衰竭患者中的水平。
Korean J Intern Med. 2019 Jul;34(4):811-818. doi: 10.3904/kjim.2017.313. Epub 2018 Dec 31.
9
[Prognostic value of measuring the diameter and inspiratory collapse of the inferior vena cava in acute heart failure].[测量下腔静脉直径及吸气塌陷在急性心力衰竭中的预后价值]
Rev Clin Esp (Barc). 2016 May;216(4):183-90. doi: 10.1016/j.rce.2015.11.012. Epub 2016 Jan 13.
10
Effects of ivabradine therapy on heart failure biomarkers.伊伐布雷定治疗对心力衰竭生物标志物的影响。
Cardiol J. 2015;22(5):501-9. doi: 10.5603/CJ.a2015.0012. Epub 2015 Mar 3.

引用本文的文献

1
Paradox of Low CA-125 in Patients with Decompensated Congestive Heart Failure.失代偿性充血性心力衰竭患者CA-125水平降低的矛盾现象。
Biomedicines. 2025 Jul 9;13(7):1679. doi: 10.3390/biomedicines13071679.

本文引用的文献

1
Clinical profiling of patients admitted with acute heart failure: a comprehensive survival analysis.急性心力衰竭住院患者的临床特征分析:一项全面的生存分析
Front Cardiovasc Med. 2024 May 21;11:1381514. doi: 10.3389/fcvm.2024.1381514. eCollection 2024.
2
Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure.糖类抗原125(CA 125):急性心力衰竭中的一种新型生物标志物。
Diagnostics (Basel). 2024 Apr 10;14(8):795. doi: 10.3390/diagnostics14080795.
3
Usefulness of myocardial damage biomarkers in predicting cardiogenic shock in patients undergoing heart valve surgery.
心肌损伤生物标志物在预测心脏瓣膜手术患者心源性休克中的应用价值。
Kardiol Pol. 2024;82(4):423-426. doi: 10.33963/v.phj.99553. Epub 2024 Mar 17.
4
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.有和没有二尖瓣反流的心力衰竭患者的生物标志物差异表达:来自BIOSTAT-CHF研究的见解
Int J Cardiol. 2024 Mar 15;399:131664. doi: 10.1016/j.ijcard.2023.131664. Epub 2023 Dec 21.
5
Carbohydrate antigen 125 in congestive heart failure: ready for clinical application?充血性心力衰竭中的糖类抗原125:准备好用于临床应用了吗?
Front Oncol. 2023 Oct 31;13:1161723. doi: 10.3389/fonc.2023.1161723. eCollection 2023.
6
Carbohydrate antigen 125 in atrial fibrillation.心房颤动中的糖类抗原125
Clin Chim Acta. 2023 Sep 1;549:117550. doi: 10.1016/j.cca.2023.117550. Epub 2023 Sep 7.
7
Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure.心力衰竭患者对达格列净治疗反应与碳水化合物抗原 125 的相关性。
J Am Coll Cardiol. 2023 Jul 11;82(2):142-157. doi: 10.1016/j.jacc.2023.05.011.
8
Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction.达格列净对射血分数降低的心力衰竭患者循环抗原碳水化合物 125 的短期影响。
Sci Rep. 2023 Jun 30;13(1):10591. doi: 10.1038/s41598-023-37491-5.
9
Clinical phenotypes according to diuretic combination in acute heart failure.急性心力衰竭中根据利尿剂联合使用情况的临床表型
Hellenic J Cardiol. 2023 Sep-Oct;73:1-7. doi: 10.1016/j.hjc.2023.03.009. Epub 2023 Apr 15.
10
Right Ventricular Failure.右心室衰竭
N Engl J Med. 2023 Mar 23;388(12):1111-1125. doi: 10.1056/NEJMra2207410.